Hypothyroidism: The Evidence-Based Supplement Protocol
Hypothyroidism is treated with thyroid hormone (levothyroxine), and no supplement replaces it — the legitimate supporting role is narrow. Selenium at 100–200 mcg/day can modestly lower thyroid antibodies in Hashimoto’s, but the evidence is very low certainty and has never been shown to improve symptoms or cut levothyroxine dose, so it is optional rather than essential. The higher-value move is to test and correct measured deficiencies of iron, vitamin B12, and vitamin D, while avoiding high-dose iodine and kelp, which can worsen autoimmune thyroiditis. Watch the interactions too: oral iron sharply cuts levothyroxine absorption, so separate them by several hours.
The single most important fact about hypothyroidism is that it is treated with thyroid hormone — levothyroxine — and no supplement replaces it. Where supplements have a legitimate role is narrower: selenium can modestly lower thyroid antibodies in Hashimoto's (the autoimmune cause of most hypothyroidism in iodine-sufficient countries), correcting documented deficiencies of iron, vitamin B12 and vitamin D can help residual symptoms, and several common supplements actively interfere with levothyroxine absorption or thyroid testing. This protocol grades each honestly and flags the interactions that matter.
Selenium 100–200 mcg/day — lowers antibodies modestly, does not replace levothyroxine
Selenium is the most-studied supplement here, and the evidence is real but weaker than marketing implies. An overview of systematic reviews (75 RCTs) found that in levothyroxine-treated Hashimoto's patients, selenium significantly reduced thyroid peroxidase antibody (TPO-Ab) levels at 3 and 6 months — but the certainty of evidence was rated very low, the effect on thyroglobulin antibodies was inconsistent, and benefit was not maintained at 12 months. A Cochrane review of four RCTs reached a similar conclusion: selenium reduced TPO-Ab titres, but the clinical relevance was unclear and the trials were at unclear-to-high risk of bias, so the evidence could "neither support nor refute" routine use. Crucially, no trial has shown selenium improves the outcomes patients care about — symptoms, quality of life, or reduced levothyroxine dose — with confidence. Grade: weak/modest, antibody surrogate only. If used, take selenomethionine 100–200 mcg/day and cap at 200 mcg; chronic intake above ~400 mcg is linked to selenosis and higher type 2 diabetes risk. See selenium.
Iodine — get adequacy, avoid excess (it can worsen autoimmune thyroiditis)
This is a caution, not a recommendation. Iodine deficiency is the leading cause of hypothyroidism worldwide but is uncommon where iodised salt is used; the adult requirement is about 150 mcg/day. More is not better. Excess iodine intake is associated with a higher incidence of autoimmune (Hashimoto's) thyroiditis and subclinical hypothyroidism, and high-dose iodine can both worsen autoimmune thyroiditis and, in nodular thyroid disease, trigger hyperthyroidism (the Jod-Basedow phenomenon). Reviews of selenium and trace-element status in autoimmune thyroiditis specifically warn against unsupervised iodine loading. Avoid high-dose iodine and kelp/seaweed supplements, whose iodine content is unpredictable, unless a clinician has documented deficiency.
Iron, vitamin B12, vitamin D — treat measured deficiencies
Hypothyroid symptoms such as fatigue overlap heavily with common deficiencies, and Hashimoto's clusters with other autoimmune conditions (pernicious anaemia, coeliac disease). Reasonable, evidence-aligned practice is to test and correct rather than supplement blindly. Iron deficiency is worth identifying and treating in symptomatic patients; note that oral iron (ferrous sulphate) markedly reduces levothyroxine absorption, so separate them by several hours. Vitamin B12 should be checked given the pernicious-anaemia overlap and repleted if low. For vitamin D, two meta-analyses of RCTs in Hashimoto's found supplementation reduced TPO-Ab and TG-Ab titres — more so with treatment longer than 12 weeks — though, as with selenium, this is an antibody surrogate rather than proof of better thyroid outcomes. Treat documented deficiency to a normal 25-OH-D level rather than chasing antibody numbers. See the iron-recovery stack and vitamin D piece.
What does not work — and what interferes with treatment
Avoid desiccated thyroid extract (NDT) and "thyroid glandular" products: the American Thyroid Association's hypothyroidism guideline found no consistent evidence that thyroid extract or levothyroxine–liothyronine combinations are superior to levothyroxine alone, and glandulars carry unpredictable, unstandardised hormone content. The bigger day-to-day issue is interference. Several supplements reduce levothyroxine absorption — calcium carbonate, ferrous sulphate (iron), and others — so any of these must be separated from the levothyroxine dose by about four hours. Soy isoflavones are a documented hazard in borderline thyroid function: in a randomised crossover trial in subclinical hypothyroidism, 16 mg of soy phytoestrogens daily tripled the rate of progression to overt hypothyroidism. High-dose biotin does not harm the thyroid but causes false thyroid lab results (falsely low TSH, falsely high free T4) — stop it for at least two days before testing. And do not add ashwagandha alongside levothyroxine without medical input, since it can raise thyroid hormone levels. See ashwagandha thyroid risk.
How to think about it
Take levothyroxine consistently and let TSH guide dosing — that, not any supplement, treats hypothyroidism. Separate calcium, iron and other binders from your levothyroxine by several hours, and stop high-dose biotin before blood tests. Test for iron, B12 and vitamin D deficiency if symptoms persist despite an in-range TSH, and correct what is actually low. In Hashimoto's, selenium and vitamin D may modestly lower antibody titres, but the evidence is low-certainty and antibody-based — neither is a substitute for hormone replacement. Avoid high-dose iodine, kelp, soy phytoestrogen supplements, and glandular/NDT products. Re-check TSH about six weeks after any change that could affect absorption.
Sources
- Wang YS, Liang SS, Ren JJ, et al. "The Effects of Selenium Supplementation in the Treatment of Autoimmune Thyroiditis: An Overview of Systematic Reviews." Nutrients, 2023;15(14):3194. PMID 37513612.
- van Zuuren EJ, Albusta AY, Fedorowicz Z, Carter B, Pijl H. "Selenium supplementation for Hashimoto's thyroiditis." Cochrane Database Syst Rev, 2013;(6):CD010223. PMID 23744563.
- Filipowicz D, Majewska K, Kalantarova A, Szczepanek-Parulska E, Ruchała M. "The rationale for selenium supplementation in patients with autoimmune thyroiditis, according to the current state of knowledge." Endokrynol Pol, 2021;72(2):153-162. PMID 33970480.
- Tang J, Shan S, Li F, Yun P. "Effects of vitamin D supplementation on autoantibodies and thyroid function in patients with Hashimoto's thyroiditis: A systematic review and meta-analysis." Medicine (Baltimore), 2023;102(52):e36759. PMID 38206745.
- Zhang J, Chen Y, Li H, Li H. "Effects of vitamin D on thyroid autoimmunity markers in Hashimoto's thyroiditis: systematic review and meta-analysis." J Int Med Res, 2021;49(12):3000605211060675. PMID 34871506.
- Sathyapalan T, Manuchehri AM, Thatcher NJ, et al. "The effect of soy phytoestrogen supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomized, double-blind, crossover study." J Clin Endocrinol Metab, 2011;96(5):1442-1449. PMID 21325465.
- Liwanpo L, Hershman JM. "Conditions and drugs interfering with thyroxine absorption." Best Pract Res Clin Endocrinol Metab, 2009;23(6):781-792. PMID 19942153.
- Jonklaas J, Bianco AC, Bauer AJ, et al. "Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement." Thyroid, 2014;24(12):1670-1751. PMID 25266247.